Literature DB >> 15334385

The multiphasic profile of free fatty acids during the intravenous glucose tolerance test is unresponsive to exogenous insulin.

A E Sumner1, R N Bergman, G L Vega, D J Genovese, C S Cochran, K Pacak, R M Watanabe, R C Boston.   

Abstract

As small increments in insulin concentration profoundly affect lipolysis, our goal was to describe the free fatty acid (FFA) profile during the frequently sampled intravenous glucose tolerance test (FSIGT) and determine if both endogenous and exogenous insulin influenced the FFA profile. Thirteen subjects had both a glucose-only (GO-FSIGT) and insulin-modified FSIGT (IM-FSIGT). Both protocols were of 6 hours duration. At baseline an intravenous glucose bolus (0.3 g/kg) was given. In the IM-FSIGT, insulin was infused from 20 to 25 minutes (4 mU/kg. min). Six additional subjects had both an IM-FSIGT and a normal saline study (NS-Study). For the NS-Study, normal saline solution was infused instead of glucose and insulin. Fasting glucose, insulin, FFA and epinephrine concentrations were similar for all tests. Endogenous insulin peaked at 4 +/- 1 minute in both FSIGTs. The mean calculated peak time of exogenous insulin in the IM-FSIGT was 26 +/- 1 minute. Glucose concentrations were lower and epinephrine concentrations higher in the IM-FSIGT versus GO-FSIGT. During the FSIGTs, the FFA time course revealed four distinct phases, which did not differ between protocols. In phase I (0 to 11 minutes), FFA levels remained near basal (491 +/- 183 micromol/L); in phase II (11 to 79 minutes), FFA levels declined achieving a nadir of 139 +/- 63 micromol/L; in phase III (79 to 188 minutes), FFA levels rose linearly and reattained basal levels; and in phase IV (188 to 360 minutes), FFA levels rose above basal and plateaued at 732 +/- 214 micromol/L (P <.001). In the NS-Study, FFA levels remained near baseline (388 +/- 118 mEq/L) until 180 minutes and then trended upward to 618 +/- 258 micromol/L at 360 minutes. FFA concentrations from 180 to 360 minutes did not differ in the IM-FSIGT versus NS-Study. As the 4 FFA phases did not differ between protocols, the insulin effect on FFA levels in the FSIGT can be attributed to endogenous insulin. But the similarity in FFA levels from 180 to 360 minutes in the IM-FSIGT and NS-Study suggests diurnal variation and not a dynamic related to insulin or the FSIGT protocol is responsible for the final suprabasal FFA plateau.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15334385     DOI: 10.1016/j.metabol.2004.03.020

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  8 in total

1.  Sleep-Disordered Breathing and Free Fatty Acid Metabolism.

Authors:  Darko Stefanovski; Ray C Boston; Naresh M Punjabi
Journal:  Chest       Date:  2020-06-18       Impact factor: 9.410

2.  5'AMP-activated protein kinase activity is increased in adipose tissue of northern elephant seal pups during prolonged fasting-induced insulin resistance.

Authors:  Jose A Viscarra; Cory D Champagne; Daniel E Crocker; Rudy M Ortiz
Journal:  J Endocrinol       Date:  2011-03-23       Impact factor: 4.286

3.  Higher acute insulin response to glucose may determine greater free fatty acid clearance in African-American women.

Authors:  Carson C Chow; Vipul Periwal; Gyorgy Csako; Madia Ricks; Amber B Courville; Bernard V Miller; Gloria L Vega; Anne E Sumner
Journal:  J Clin Endocrinol Metab       Date:  2011-05-18       Impact factor: 5.958

4.  NEFA minimal model parameters estimated from the oral glucose tolerance test and the meal tolerance test.

Authors:  Ray C Boston; Peter J Moate
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-06-18       Impact factor: 3.619

5.  Evaluation of quantitative models of the effect of insulin on lipolysis and glucose disposal.

Authors:  Vipul Periwal; Carson C Chow; Richard N Bergman; Madia Ricks; Gloria L Vega; Anne E Sumner
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-08-06       Impact factor: 3.619

6.  Human biallelic MFN2 mutations induce mitochondrial dysfunction, upper body adipose hyperplasia, and suppression of leptin expression.

Authors:  Nuno Rocha; David A Bulger; Andrea Frontini; Hannah Titheradge; Sigrid Bjerge Gribsholt; Rachel Knox; Matthew Page; Julie Harris; Felicity Payne; Claire Adams; Alison Sleigh; John Crawford; Anette Prior Gjesing; Jette Bork-Jensen; Oluf Pedersen; Inês Barroso; Torben Hansen; Helen Cox; Mary Reilly; Alex Rossor; Rebecca J Brown; Simeon I Taylor; Duncan McHale; Martin Armstrong; Elif A Oral; Vladimir Saudek; Stephen O'Rahilly; Eamonn R Maher; Bjørn Richelsen; David B Savage; Robert K Semple
Journal:  Elife       Date:  2017-04-19       Impact factor: 8.140

7.  Insulin Action, Glucose Homeostasis and Free Fatty Acid Metabolism: Insights From a Novel Model.

Authors:  Darko Stefanovski; Naresh M Punjabi; Raymond C Boston; Richard M Watanabe
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-16       Impact factor: 5.555

8.  Effect of DDT exposure on lipids and energy balance in obese Sprague-Dawley rats before and after weight loss.

Authors:  Tomoko Ishikawa; James L Graham; Kimber L Stanhope; Peter J Havel; Michele A La Merrill
Journal:  Toxicol Rep       Date:  2015-07-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.